Precision Medicine Market Size, Share, Trends, Analysis and Forecast Till 2028
According to IMARC Group’s latest report, titled “Precision
Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and
Forecast 2023-2028”, The study provides a detailed analysis of the
industry, including the global precision
medicine market share, size, trends, and growth forecasts. The report
also includes competitor and regional analysis and highlights the latest
advancements in the market.
How big is the precision medicine market?
The global precision medicine market size reached US$ 68.1
Billion in 2022. Looking forward, IMARC Group expects the market to reach US$
123.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.7% during
2023-2028.
What is precision medicine?
Precision medicine harnesses the unique interplay of a
person's environment, genetic makeup, and lifestyle to prevent and diagnose
diseases. This personalized approach helps predict an individual's
susceptibility to various diseases, improves disease detection, and facilitates
more effective drug prescriptions. It is a cost-effective and time-saving
method that reduces the failure rate of pharmaceutical clinical trials,
benefiting patients and pharmaceutical companies alike. It is widely utilized
in predicting the risk of genetic disorders being passed on to offspring and
diagnosing chromosomal abnormalities in the fetus, which is especially crucial
in prenatal care.
The approach relies on various tools, including advanced
imaging, genetic testing, and sophisticated data analytics. By analyzing large
amounts of data, physicians can study the root cause of disease and develop
more targeted treatments that address the specific needs of each patient.
Request for a sample report or buy full report: https://www.imarcgroup.com/precision-medicine-market/requestsample
What are the growth prospects and trends in the
precision medicine industry?
The COVID-19 pandemic has burgeoned the need for precision
medicine, which represents one of the primary factors boosting precision
medicine market growth. Additionally, the increasing prevalence of cancer has
surged the demand for precision medicine in the diagnosis, treatment, and
monitoring of cancer patients, which, in turn, is propelling the market growth.
Furthermore, the expanding pipeline of drug candidates in
clinical trials, particularly in the field of oncology, has provided a strong
impetus to market growth. Apart from this, the industry has witnessed
substantial investments in research and development (R&D) initiatives aimed
at developing cost-effective and advanced techniques, such as targeted
sequencing, enabling precise treatment strategies, which is favoring the market
growth.
Who are the key players operating in the precision
medicine market?
The competitive landscape of the industry has also been
examined along with the profiles of the key players:
- AstraZeneca
plc
- Bayer AG
- BioMérieux
SA
- Bristol-Myers
Squibb Company
- Eli Lilly
and Company
- Hoffmann-La
Roche AG
- Illumina
Inc.
- Laboratory
Corporation of America Holdings
- Merck
KGaA, Novartis AG
- Pfizer
Inc.
- Qiagen
N.V.
- Quest
Diagnostics Incorporated
- Thermo
Fisher Scientific Inc.
What is Included in market segmentation?
The report has categorized the market based on
product, technology, application, end user and region.
Breakup by Product:
- Consumables
- Instruments
- Services
Breakup by Technology:
- Big Data
Analytics
- Bioinformatics
- Gene
Sequencing
- Drug
Discovery
- Companion
Diagnostics
- Others
Breakup by Application:
- Oncology
- Central
Nervous System (CNS)
- Immunology
- Respiratory
Medicine
- Infections
- Others
Breakup by End User:
- Hospitals
and Clinics
- Diagnostic
Centers
- Pharma and
Biotech Companies
- Healthcare
IT Firms
- Others
Breakup by Region:
- North
America (United States, Canada)
- Europe
(Germany, France, United Kingdom, Italy, Spain, Others)
- Asia
Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin
America (Brazil, Mexico, Others)
- Middle
East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South
Africa, Others)
Ask Analyst for Customization and
Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4567&flag=C
Key Highlights of The Report:
- Market
Performance (2017-2022)
- Market
Outlook (2023-2028)
- Market
Trends
- Market
Drivers and Success Factors
- SWOT
Analysis
- Value
Chain Analysis
- Comprehensive
mapping of the competitive landscape
If you need specific information that is not
currently within the scope of the report, we will provide it to you as a part
of the customization.
About Us:
IMARC Group is a leading market research company that
offers management strategy and market research worldwide. We partner with
clients in all sectors and regions to identify their highest-value
opportunities, address their most critical challenges, and transform their
businesses.
IMARC’s information products include major market,
scientific, economic and technological developments for business leaders in pharmaceutical,
industrial, and high technology organizations. Market forecasts and industry
analysis for biotechnology, advanced materials, pharmaceuticals, food and
beverage, travel and tourism, nanotechnology and novel processing methods are
at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249,
USA
USA: +1-631-791-1145 | Asia:
+91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: https://twitter.com/ImarcServices
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
Comments
Post a Comment